MetaVia Inc. 8-K

What Happened MetaVia Inc. filed a Form 8‑K on July 2, 2026 disclosing an at-the-market equity program under a Sales Agreement entered November 6, 2025 with Ladenburg Thalmann & Co. Inc. The company filed a prospectus supplement on July 2, 2026 to offer and sell up to $4,000,000 of its common stock (par value $0.001) from time to time through or to Ladenburg. Honigman LLP provided a legal opinion on the validity of the shares (filed as Exhibit 5.1).

Key Details

• Sales agreement date: November 6, 2025 (with Ladenburg Thalmann & Co. Inc. as sales agent/principal)
• Prospectus filed: July 2, 2026 (prospectus supplement for the offering)
• Offering size: Up to $4,000,000 of common stock under the at-the-market program
• Legal counsel: Opinion from Honigman LLP filed as Exhibit 5.1

Why It Matters An at-the-market offering lets MetaVia raise capital by selling shares into the open market over time at prevailing prices, providing flexibility and potentially quicker access to funds than a traditional secondary offering. If shares are sold under this program, existing shareholders could experience dilution depending on the number of shares issued and the sale prices. The filing does not specify the planned use of proceeds. This disclosure is material because it affects the company’s capital structure and could influence the stock’s supply and price.